Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Endoceutics
Endoceutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Intrarosa
Prasterone
2018-01-08
2028-2031
Adrenal insufficiency
,
Dyspareunia
,
Postmenopause
,
Sexual and gender disorders
,
Lupus vulgaris
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Prasterone
atrophy
,
atrophic vaginitis
,
hypokinesia
,
psychological sexual dysfunctions
,
breast neoplasms
,
flushing
,
hot flashes
,
dyspareunia
,
syndrome
,
menopause
Antithrombin iii
breast neoplasms
,
atrophy
Gl701
atrophy
,
atrophic vaginitis
,
hypokinesia
,
psychological sexual dysfunctions
,
breast neoplasms
,
flushing
,
hot flashes
,
dyspareunia
,
syndrome
,
menopause
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use